Want to join the conversation?
During 4Q16, $DV's Medical and Healthcare segment revenue rose 8% vs. 4Q15, helped by solid growth at Chamberlain. International and Professional Education segment revenues rose 27.5% vs. 4Q15, driven by acquisitions and organic growth, while Business, Technology, and Management segment revenue fell 23.4% vs. 4Q15.
$YHOO is reporting today after market close. Nobody cares about this stock.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.